Business Description
PharmaEssentia Corp
ISIN : US7169722037
Share Class Description:
LUX:PHECR: GDR - Reg SCompare
Compare
Traded in other countries / regions
6446.TaiwanPHECR.Luxembourg IPO Date
2023-04-18Description
PharmaEssentia Corp is engaged in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug pattern developments. It focuses on Hematology, Oncology, and Infectious Disease. The company derives its revenue from sales of medicine products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.66 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.67 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 44.46 | |||||
| Beneish M-Score | -1.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 91 | |||||
| 3-Year EBITDA Growth Rate | 33.9 | |||||
| 3-Year EPS without NRI Growth Rate | 37.6 | |||||
| 3-Year FCF Growth Rate | 2.4 | |||||
| 3-Year Book Growth Rate | 69.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 58.63 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.1 | |||||
| 9-Day RSI | 72.13 | |||||
| 14-Day RSI | 73.13 | |||||
| 6-1 Month Momentum % | 80.81 | |||||
| 12-1 Month Momentum % | 81.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.78 | |||||
| Quick Ratio | 12.1 | |||||
| Cash Ratio | 10.78 | |||||
| Days Inventory | 587.92 | |||||
| Days Sales Outstanding | 80.91 | |||||
| Days Payable | 57.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.9 | |||||
| Shareholder Yield % | 1.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.46 | |||||
| Operating Margin % | -4.59 | |||||
| Net Margin % | 19.16 | |||||
| FCF Margin % | -2.44 | |||||
| ROE % | 5.4 | |||||
| ROA % | 4.83 | |||||
| ROIC % | -5.68 | |||||
| 3-Year ROIIC % | 11.58 | |||||
| ROC (Joel Greenblatt) % | 31.69 | |||||
| ROCE % | 4.94 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 153.32 | |||||
| Forward PE Ratio | 37.53 | |||||
| PE Ratio without NRI | 153.32 | |||||
| Price-to-Owner-Earnings | 498 | |||||
| PEG Ratio | 33.33 | |||||
| PS Ratio | 29.31 | |||||
| PB Ratio | 8.18 | |||||
| Price-to-Tangible-Book | 8.27 | |||||
| Price-to-Operating-Cash-Flow | 218.03 | |||||
| EV-to-EBIT | 149 | |||||
| EV-to-EBITDA | 117.19 | |||||
| EV-to-Revenue | 27.12 | |||||
| EV-to-FCF | -1359.35 | |||||
| Price-to-Graham-Number | 7.52 | |||||
| Price-to-Net-Current-Asset-Value | 9.89 | |||||
| Price-to-Net-Cash | 12.05 | |||||
| Earnings Yield (Greenblatt) % | 0.67 | |||||
| FCF Yield % | -0.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmaEssentia Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 216.873 | ||
| EPS (TTM) ($) | 0.127 | ||
| Beta | 0 | ||
| Volatility % | 47.58 | ||
| 14-Day RSI | 73.13 | ||
| 14-Day ATR ($) | 0.001431 | ||
| 20-Day SMA ($) | 18.2 | ||
| 12-1 Month Momentum % | 81.42 | ||
| 52-Week Range ($) | 9.486 - 18.2 | ||
| Shares Outstanding (Mil) | 330.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmaEssentia Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmaEssentia Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmaEssentia Corp Frequently Asked Questions
What is PharmaEssentia Corp(LUX:PHECR)'s stock price today?
The current price of LUX:PHECR is $18.20. The 52 week high of LUX:PHECR is $18.20 and 52 week low is $9.49.
When is next earnings date of PharmaEssentia Corp(LUX:PHECR)?
The next earnings date of PharmaEssentia Corp(LUX:PHECR) is .
Does PharmaEssentia Corp(LUX:PHECR) pay dividends? If so, how much?
PharmaEssentia Corp(LUX:PHECR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers